Toward better drug development: Three-dimensional bioprinting in toxicological research
International Journal of Bioprinting · 06.01.2023 · 9 (2) · 663
DOI: 10.18063/ijb.v9i2.663 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Bioprinting, online erschienen am 06.01.2023. Verfasst von Diána Szűcs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine and Cellular Pharmacology Laboratory (HECRIN), Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The importance of three-dimensional (3D) models in pharmacological tests and personalized therapies is significant. These models allow us to gain insight into the cell response during drug absorption, distribution, metabolism, and elimination in an organlike system and are suitable for toxicological testing. In personalized and regenerative medicine, the precise characterization of artificial tissues or drug metabolism processes is more than crucial to gain the safest and the most effective treatment for the patients. Using these 3D cell cultures derived directly from patient, such as spheroids, organoids, and bioprinted structures, allows for testing drugs before administration to the patient. These methods allow us to select the most appropriate drug for the patient. Moreover, they provide chance for better recovery of patients, since time is not wasted during therapy switching. These models could be used in applied and basic research as well, because their response to treatments is quite similar to that of the native tissue. Furthermore, they may replace animal models in the future because these methods are cheaper and can avoid interspecies differences. This review puts a spotlight on this dynamically evolving area and its application in toxicological testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenerative Medicine and Cellular Pharmacology Laboratory (HECRIN), Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
- Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
- Interdisciplinary Research Development and Innovation, Center of Excellence, University of Szeged, Szeged, Hungary.
- Solvo Biotech, Szeged, Hungary.
- Hungarian Centre of Excellence for Molecular Medicine-University of Szeged Skin Research Group (HCEMM-USZ Skin Research Group), University of Szeged, Szeged, Hungary.
- 3D Center, University of Szeged, Szeged, Hungary.
Zitieren
APA
Szűcs, D., Fekete, Z., Guba, M., Kemény, L., Jemnitz, K., Kis, E., & Veréb, Z. (2023). Toward better drug development: Three-dimensional bioprinting in toxicological research. International Journal of Bioprinting, 9(2), 663. https://doi.org/10.18063/ijb.v9i2.663
Vancouver
Szűcs D, Fekete Z, Guba M, Kemény L, Jemnitz K, Kis E, et al. Toward better drug development: Three-dimensional bioprinting in toxicological research. International Journal of Bioprinting. 2023;9(2):663. doi:10.18063/ijb.v9i2.663
BibTeX
@article{Szcs2023,
author = {Szűcs, Diána and Fekete, Zsolt and Guba, Melinda and Kemény, Lajos and Jemnitz, Katalin and Kis, Emese and Veréb, Zoltán},
title = {Toward better drug development: Three-dimensional bioprinting in toxicological research},
journal = {International Journal of Bioprinting},
year = {2023},
volume = {9},
number = {2},
pages = {663},
doi = {10.18063/ijb.v9i2.663}
}
EUVIMED